Immix Biopharma Inc (IMMX) Business News Jan. 28, 2026, 13:45 UTC Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201 Full text
Register to leave comments News bot Jan. 28, 2026, 8:04 p.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General